Accelera and CROSS: an integrated solution for Pre-clinical to Clinical transition
May 17, 2021
May 2021 – The relationship between Accelera and CROss Alliance®…
Read more
News Archive
CROSS Research participation in phase 1 study with monoclonal antibody against SARS-COV2
Mar 9, 2021
March 2021 – CROss Alliance® is excited to share …
Read more
Participation of CROss Alliance® in the Zurich Life Science Day 2021
Feb 11, 2021
February 2021 – On the 4th of February, Ursula …
Read more
Covid-19 – Phase I unit re-open
Jun 23, 2020
June 2020 – We are relieved to announce that CROSS …
Read more
Covid-19 – CROss Alliance® measures
Apr 2, 2020
2nd April 2020 – Almost one month has passed …
Read more
Covid-19 – CROss Alliance® update
Mar 9, 2020
March 2020 – CROss Alliance® would like to inform its …
Read more
Merger by incorporation of CROSS Metrics SA in CROSS Research SA
Jan 10, 2020
January 2020 – CROss Alliance® would like to announce …
Read more
Merry Christmas & Happy New Year Wishes
Dec 19, 2019
At CROss Alliance® Christmas time represents an opportunity to evaluate …
Read more
Switzerland as a potentially safe and trustable “Cloud Region”
Oct 16, 2019
October 2019 – CROss Alliance® operates in Switzerland in full …
Read more
Nordic Life Science Day 2019
Sep 27, 2019
September 2019 – For the third consecutive year CROss Alliance®…
Read more